Related Experiment Video
Updated: Aug 11, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
The commercialization of university-based research: Balancing risks and benefits
Timothy Caulfield1, Ubaka Ogbogu2
1461 Law Centre, University of Alberta, 111 St and 89 Ave, Edmonton, AB, T6G 2H5, Canada. caulfield@ualberta.ca.
Background:
The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanced assessment of the commercialization ethos and trends.
Discussion:
There is growing evidence that the pressure to commercialize is directly or indirectly associated with adverse impacts on the research environment, science hype, premature implementation or translation of research results, loss of public trust in the university research enterprise, research policy conflicts and confusion, and damage to the long-term contributions of university research. The growing emphasis on commercialization of university research may be exerting unfounded pressure on researchers and misrepresenting scientific research realities, prospects and outcomes. While more research is needed to verify the potential risks outlined in this paper, policy discussions should, at a minimum, acknowledge them.
Related Concept Videos
Ethics in Research
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

